UNCY7:05 AMUnicycive Therapeutics Receives Complete Response Letter from FDA Regarding Resubmitted Oxylanthanum Carbonate (OLC) New Drug Application (NDA)unicycive.com
UNCY7:05 AMUnicycive Therapeutics Announces First Quarter 2026 Financial Results and Provides Business Updateunicycive.com